- Poster presentation
- Open Access
Novel phenotypic resistance to artemisinin results in reduced exposure to drug at the most sensitive stage of intraerythrocytic development in Plasmodium falciparum
© Hott et al; licensee BioMed Central Ltd. 2014
- Published: 22 September 2014
- Plasmodium Falciparum
- Phenotypic Resistance
- Parasite Clearance
- Resistant Clone
- Artemisinin Resistance
Recent emergence of artemisinin resistant Plasmodium falciparum in Southeast Asia has threatened malaria control efforts across the globe. Clinical resistance is characterized by reduced rates of parasite clearance following treatment; yet in vitro phenotypes of artemisinin resistance suitable for elucidating molecular mechanisms of resistance remain elusive.
In this study we culture adapted and characterized a series of P. falciparum clones from Cambodia; these included parasites from cases with reduced parasite clearance rates in vivo. In vitro artemisinin resistance phenotypes were assessed by using T0 3H-hypoxanthine assays, a novel parasite clearance assay, microscopy and flow cytometry to characterize intraerythrocytic development, and limiting dilution to assess parasite viability.
Detailed phenotypic characterization of artemisinin resistant P. falciparum revealed a series of complex phenotypes that included 4-8 fold resistance to multiple artemisinin derivatives in vitro that is stable for >1 year. By using a novel parasite clearance assay we observed reduced parasite reduction rates (PRRs) for resistant clones in vitro and these were positively correlated with parasitemia clearance half-lives in vivo. Most remarkably we discovered an altered pattern of intraerythrocytic development of the artemisinin resistant clones of P. falciparum. In the absence of any drug pressure, resistant clones exhibited a prolonged phase of ring stage development followed by a significantly shortened trophozoite stage of development. Given that ring stages are the most resistant to inhibition by artemisinin and the trophozoites are the most susceptible, this novel phenotypic resistance to artemisinin results in reduced exposure to drug at the most sensitive stage of development (trophozoite). Additional confirmation of the selective pressure driving this phenotype is one resistant clone exhibited a 12 hour shorter erythrocytic life cycle that also compressed the trophozoite stage of development.
The evolution of artemisinin resistance appears to select for altered intraerythrocytic development such that the most susceptible stage of development is significantly reduced in the cell cycle. Our data demonstrate that altered intraerythrocytic development is a novel mechanism of phenotypic resistance to artemisinin antimalarial drugs.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.